A Phase I Study of a Tropism Modified Conditionally Replicative Adenovirus (CRAd) for Recurrent Gynecologic Malignancies

PURPOSE: To determine the maximum tolerated dose (MTD), toxicity spectrum, clinical activity, and biological effects of the tropism-modified infectivity-enhanced CRAd, Ad5-Δ24-RGD, in patients with gynecologic malignancies. EXPERIMENTAL DESIGN: Cohorts of eligible patients were treated daily for 3 d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kimball, Kristopher J., Preuss, Meredith A., Barnes, Mack N., Wang, Minghui, Siegal, Gene P., Wan, Wen, Kuo, Huichien, Saddekni, Souheil, Stockard, Cecil R., Grizzle, William E., Harris, Raymond D., Aurigemma, Rosemarie, Curiel, David T., Alvarez, Ronald D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2970766/
https://ncbi.nlm.nih.gov/pubmed/20978148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0791
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados